Updated:
MedSciences Capital
MedSciences Capital is a private equity firm based in Amsterdam, Netherlands. It focuses on a Venture Capital strategy. The firm has a team of two staff,...
MedSciences Capital
MedSciences Capital is a private equity firm based in Amsterdam, Netherlands. It focuses on a Venture Capital strategy. The firm has a team of two staff, including two investment professionals.
General information
Firm type
Private Equity
Year founded
2000
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Amsterdam
Corporate office
Amsterdam, Netherlands
Additional offices
The Hague, Netherlands
Principals
Willem P. van Lawick
Founder
Otto H. Postma
Co-founder
Sector focus
Frequently asked questions
Who runs investment decisions at MedSciences Capital?
Willem P. van Lawick, the firm's founder, leads investment decisions. He holds a medical degree from Leiden University and an MBA from INSEAD, and serves on the boards of several MSC portfolio companies. Otto H. Postma, who co-founded the predecessor to Pharming Group N.V., works alongside him, bringing chemistry and commercial-development expertise.
How does MedSciences Capital source proprietary deal flow?
The firm relies on its principals' deep clinical and operational networks within the European medical life sciences community. Van Lawick's background as a physician and Postma's track record in biotech startups and licensing provide direct access to academic spinouts and early-stage product developers. The firm does not publicly detail a formal sourcing model.
Is MedSciences Capital structured as a family office or a venture firm?
MedSciences Capital is structured as a venture capital asset manager, not a family office. It manages multiple pooled investment vehicles, including MSC I, MSC II, and the government-supported MedSciences Seed Fund. The management company is MedSciences Capital Management B.V.
Does MedSciences Capital participate in fund commitments or only direct deals?
The firm makes direct venture investments into early- and mid-stage companies. Its three vehicles — two early-stage venture funds and a TechnoPartner seed fund — all take direct equity positions. There is no known fund-of-funds activity.
What investment stages does MedSciences Capital target?
MSC targets early-stage, seed, and start-up companies, extending into mid-stage ventures within the medical life sciences sector. Its MedSciences Seed Fund specifically addresses the earliest company formation stage, supported by the Dutch TechnoPartner program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: